All optical control and monitoring of neural activity
All optical control and monitoring of neural activity
批准号:
8638689
负责人:
Samarendra Kumar Mohanty
金额:
$17.61万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-15 至 2015-08-31
关键词:
Animal ModelCell Culture TechniquesCellsClinical TreatmentControlled StudyDetectionDevelopmentElectric StimulationElectrophysiology (science)ElectroporationEmbryoFrequenciesGanglion Cell LayerGene DeliveryGene TransferGenesGeneticGoalsHuman ActivitiesImageIn VitroInflammatory ResponseInterferometryInterventionLabelLasersLengthLightLocationMeasuresMethodsMolecularMonitorNeuronsOpsinOptical Coherence TomographyOpticsPatientsPatternPeripheralPhasePhotoreceptorsPhysiologic pulsePlaguePlasmidsProteinsRattusReactionResolutionRetinaRetinal Ganglion CellsRetinitis PigmentosaSignal TransductionSourceStagingSystemTechniquesTechnologyTissuesTransfectionViralViral VectorWidthbaseblindcell typehuman diseasein vivokidney cellminimally invasivenanonanometernoveloptogeneticspromoterpublic health relevancerelating to nervous systemsuccess
中文摘要
项目总结:光遗传神经活动干预的成功需要优化
将编码光敏蛋白(Opsins)的基因传递到特定的细胞,并记录
光发生刺激过程中细胞和组织的变化。最常用的方法是
传递视蛋白(S)是使用病毒载体,容易引起意想不到的炎症
反应、免疫反应和不适当的基因整合。此外,病毒方法
限制可包装和递送的质粒的大小,因此不能携带多个
视蛋白编码基因或大启动子。此外,在一些人类疾病的案例中,例如
视网膜色素变性(RP)周围视网膜发生进行性的光感受器丧失,它
将有助于定位opsins的表达,不仅在特定的细胞类型中,而且在
受限制的空间区域(在RP中为周边)。该提案的第一个目标是优化一种非病毒
减轻病毒传播带来的挑战的传播方法。我们最近使用了Focus
近红外超快激光束方法将视黄素(ChR2)输送到空间图案区
神经组织(视网膜)。但是,该技术需要进行优化,以最大限度地减少
有害的影响。此外,开发无标记光学技术将被证明是有用的(相比之下
到电生理学)无创地评估光遗传敏化的功能激活
具有高空间分辨率和大吞吐量的神经元。最近,我们演示了如何使用
相敏频域光学相干层析成像(PSFD-OCT)
光基因刺激细胞的波动。PSFD-OCT是一种基于
可探测几十个数量级位移的低相干干涉测量原理
皮克计。由于光的低相干长度,检测到的信号必须在
光源的相干长度(~10?m)。这使PSFD-OCT能够调查
纳米在组织体积的非常小的区域内变化,并且适合于高度
局部化检测。本研究的总体目标是优化基因编码的光学传递
OPTINS,并开发了基于PSFD-OCT的无标签非侵入性光学读出方法
监测激活引起的大脑皮层神经元和组织的变化。
1
英文摘要
Project Summary: Success of optogenetic intervention of neural activity requires optimization of
delivery of genes encoding light sensitive proteins (opsins) to specific cells, and to record the
changes in cells and tissue during optogenetic stimulation. The most-commonly used method for
delivering opsin(s) is use of viral vector, which is prone to cause unexpected inflammatory
responses, immunological reactions, and improper gene integration. Further, the viral methods
limit the size of plasmid that can be packaged and delivered and therefore cannot carry multiple
opsin-encoding genes or large promoters. Further, in several cases of human diseases such as
retinitis pigmentosa (RP) where progressive loss of photoreceptors happens in peripheral retina, it
will be useful to localize the expression of the opsins not only in specific cell types, but in a
restricted spatial region (peripheral in RP). The first aim of the proposal is to optimize a non-viral
delivery method to mitigate the challenges posed by viral delivery. We have recently used focused
near-IR ultrafast laser beam method to deliver opsins (ChR2) into spatially-patterned regions of
neural tissue (retina). However, this technique needs to be optimized so as to minimize the
deleterious effects. Further, it will prove useful to develop a label-free optical technique (in contrast
to electrophysiology) to non-invasively evaluate functional activation of optogenetically-sensitized
neurons with high spatial resolution and large throughput. Recently, we demonstrated use of
Phase-Sensitive Frequency Domain Optical Coherence Tomography (PSFD-OCT) for detection of
fluctuations in optogenetically-stimulated cells. PSFD-OCT is a novel technique based on the
principles of low-coherence interferometry that can detect displacements of the order of tens of
picometers. Because of the low-coherence length of the light, the detected signal has to be within
the coherence length of the light source (~10¿m). This enables PSFD-OCT to investigate sub-
nanometer changes within a very small region of the tissue volume and is suitable for highly
localized detection. The overall aim of this study is to optimize optical delivery of gene encoding
opsins, and develop label-free non-invasive optical readout method based on PSFD-OCT to
monitor the changes in cortical neurons and tissue resulting from the activation.
1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Nano-enhanced Optical Delivery of opsin for dry-AMD therapy
-
批准号:10011324
-
项目类别:
-
资助金额:$77.99万
-
财政年份:2020
-
负责人:Samarendra Kumar Mohanty
-
依托单位:
Targeted Nano-enhanced Optical Delivery of opsin for dry-AMD therapy
-
批准号:10431987
-
项目类别:
-
资助金额:$65.62万
-
财政年份:2020
-
负责人:Samarendra Kumar Mohanty
-
依托单位:
Bioluminescent Multi-Characteristic Opsin for simultaneous optical stimulation and large-scale monitoring of the visual system
-
批准号:10206147
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2018
-
负责人:Samarendra Kumar Mohanty
-
依托单位:
Bioluminescent Multi-Characteristic Opsin for simultaneous optical stimulation and large-scale monitoring of the visual system
-
批准号:10433927
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2018
-
负责人:Samarendra Kumar Mohanty
-
依托单位:
Ambient light activatable opsin based therapy for age-related macular degeneration
-
批准号:10256368
-
项目类别:
-
资助金额:$74.95万
-
财政年份:2015
-
负责人:Samarendra Kumar Mohanty
-
依托单位:
AMBIENT LIGHT ACTIVATABLE OPSIN BASED THERAPY FOR AGE-RELATED MACULAR DEGENERATION
-
批准号:9975579
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2015
-
负责人:Samarendra Kumar Mohanty
-
依托单位:
Ambient light activatable opsin based therapy for age-related macular degeneration
-
批准号:9789322
-
项目类别:
-
资助金额:$95.04万
-
财政年份:2015
-
负责人:Samarendra Kumar Mohanty
-
依托单位:
海外基金